Originally published In Press as doi:10.1074/jbc.M106342200 on February 5, 2002
J. Biol. Chem., Vol. 277, Issue 16, 13973-13982, April 19, 2002
Structure-Function Analysis of NADE
IDENTIFICATION OF REGIONS THAT MEDIATE NERVE GROWTH
FACTOR-INDUCED APOPTOSIS*
Jun
Mukai
,
Shisako
Shoji§,
Makoto T.
Kimura§,
Shuichi
Okubo
,
Hajime
Sano
¶,
Petro
Suvanto
,
Yin
Li
,
Shinji
Irie§, and
Taka-Aki
Sato
From the
Division of Molecular Oncology, Department
of Otolaryngology/Head & Neck Surgery and Pathology, College of
Physicians & Surgeons, Columbia University, New York, New York 10032 and the § Molecular Oncology Laboratory, RIKEN (Institute of
Physical and Chemical Research), Ibaraki 305-0074, Japan
Received for publication, September 16, 2001, and in revised form, December 20, 2001
 |
ABSTRACT |
Nerve growth factor (NGF) can induce apoptosis in
neural cells via activation of the low affinity neurotrophin receptor
p75NTR. NADE (p75NTR-associated cell
death executor) is a p75NTR-associated protein
that mediates apoptosis in response to NGF by interacting with the
death domain of p75NTR in 293T, PC12, and nnr5 cells (Mukai, J.,
Hachiya, T., Shoji-Hoshino, S., Kimura, M. T., Nadano, D.,
Suvanto, P., Hanaoka, T., Li, Y., Irie, S., Greene, L. A., and
Sato, T. A. (2000) J. Biol. Chem. 275, 17566-17570). We performed extensive mutational analysis on NADE, to
better characterize its structural and functional features. Truncation
of a minimal region, including amino acid residues 41-71 of NADE, was
found to be sufficient to induce apoptosis. The designated regulatory region includes the C-terminal amino acid residues (72-112) and is
essential for NGF-dependent regulation of NADE-induced
apoptosis. Furthermore, the mutants with amino acid substitutions in
the leucine-rich nuclear export signal (NES) sequence (residues
90-100) abolished the export of NADE from the nucleus to the
cytoplasm. Mutation of the NES also abolished self-association of NADE,
its interaction with p75NTR, and NGF-dependent apoptosis.
Expression of a fragment of NADE (amino acid residues 81-124) blocked
NGF-induced apoptosis in oligodendrocytes, suggesting that this region
has a dominant negative effect on NGF/p75NTR-induced apoptosis. These studies identify distinct regions of NADE that are involved in regulating specific functions involved in p75NTR signal transduction.
 |
INTRODUCTION |
Many mammalian cells undergo apoptosis in response to various
stimuli, including DNA damage, growth factor deprivation, and abnormal
expression of oncogenes or tumor suppressor genes (1-3). Apoptosis
induced by these various signals appears to be mediated by a common set
of downstream elements that act as regulators and effectors of
programmed cell death. Apoptosis also occurs during the course of
normal development. In neural cells, neurotrophins have been shown to
promote apoptosis during development (4). Nerve growth factor
(NGF)1 was first identified
as a growth factor that is required for the survival of specific
neuronal cells during normal development (5). However, more recently,
it has been shown that NGF has other diverse effects on the nervous
system, including differentiation and apoptosis (4-6).
NGF recognizes at least two cell surface receptors, the high affinity
tyrosine kinase receptor (TrkA) and the low affinity non-tyrosine
kinase type receptor p75 neurotrophin receptor (p75NTR) (7-9). TrkA
contains a tyrosine kinase motif within its intracellular region.
Binding of NGF to TrkA activates the kinase and subsequently induces
phosphorylation of multiple substrates that lead to the activation of
mitogen-activated protein (MAP) kinase, phosphatidylinositol 3-kinase, and other intracellular signaling cascades (10, 11). The TrkA receptor promotes cell survival and initiates differentiation signals in neuronal cells (12, 13). In contrast, p75NTR, which is a
member of the tumor necrosis factor (TNF) receptor superfamily, mediates neurotrophin-induced apoptosis (14). Several lines of evidence
from various systems, including cultured cells as well as knockout and
transgenic mice, suggest that p75NTR has a pro-apoptotic role (15-19).
Furthermore, NGF induces apoptosis in terminally differentiated primary
oligodendrocytes expressing p75NTR (20). These studies suggested that
p75NTR is involved in NGF-induced apoptosis. The only known consensus
motif within the intracellular domain of p75NTR is a death domain,
similar to that found in the p55 tumor necrosis factor receptor
(p55TNFR) and in Fas. However, the molecular mechanisms by which p75NTR mediates pro-apoptotic signaling have not been well characterized.
Recently, members of the TNF receptor-associated factor (TRAF) family,
FAP-1, SC-1, NRIF, NRAGE, and RhoA, have been reported to interact with
the intracellular domain (ICD) of p75NTR (21-27). Of these, TRAF2,
NRIF, and NRAGE have been reported to function in the p75NTR-mediated
apoptotic pathway. Co-expression of TRAF2 with p75NTR enhanced cell
death (22), whereas co-expression of TRAF6 was cytoprotective (21).
NRIF is known to block cell division. The retinae of
nrif
/
mice show reduced cell death,
and this reduction is quantitatively similar to that seen in
p75
/
and ngf
/
mice (25). NRAGE binds with p75NTR both in vitro and
in vivo and blocks the physical association of p75NTR with
TrkA. NRAGE overexpression facilitates cell cycle arrest and permits
NGF-dependent apoptosis within sympathetic neuron precursor
cells (26). However, the mechanisms of p75NTR-mediated signal
transduction are still not fully understood. Recently, we identified a
novel protein that we termed p75NTR-associated
cell death executor (NADE), which associated
with the p75NTR(ICD) in a yeast two-hybrid screen (28). A data base
search using the putative NADE amino acid sequence identified a
homologous, partially characterized human cDNA clone termed
HGR74/Bex3 (29). Co-expression of NADE and p75NTR induced cell death in
293T cells. NGF induced a dose-dependent association of
NADE with the death domain of p75NTR, and p75NTR·NADE-induced cell death required NGF but not BDNF, NT-3, or NT-4/5. Similar results
were also obtained in PC12 and PC12 nnr5 cells (28). After forebrain
ischemia, p75NTR and NADE gene expression were induced in degenerating rat hippocampal CA1 neurons. NADE contributes to p75NTR-induced cortical neuronal death (30). Furthermore, 14-3-3 proteins associate with NADE and play a role in p75NTR·NADE-mediated apoptosis in HEK293 cells, PC12 nnr5 cells, and oligodendrocytes (31).
NADE has a nuclear export signal (NES) consensus motif, which is both
necessary and sufficient to mediate nuclear export of large carrier
proteins (32). Recent reports have demonstrated that the cellular
localization of many proteins is tightly regulated by this motif,
including that of HIV-Rev (33), PKI (34), and MAPKK (35). Thus, the
NES-mediated intracellular transport system is a widely conserved
mechanism that controls the subcellular localization of proteins in cells.
In this study, we have analyzed three issues relating to the functional
and structural properties of mouse NADE. First, by mutational analysis,
we have defined the subregions of NADE that are required for
NGF-induced cell death. Second, we have shown that NADE contains a
functional NES domain and that this sequence is responsible for
self-association, interaction with p75NTR and induction of cell death.
Finally, we have identified a dominant negative form of NADE, comprised
of amino acids 81-124, which inhibited NGF-induced apoptosis in oligodendrocytes.
 |
EXPERIMENTAL PROCEDURES |
Constructs--
NADE (WT)
(pcDNA3.1/Myc-His(
)A/mNADE WT) was constructed as described
previously (28). Expression vectors for mouse NADE deletion mutants
were constructed by PCR amplification of NADE coding
sequences using oligonucleotide pairs as shown, digesting the resulting
fragments with XhoI/BamHI, and ligating the
resulting fragments into XhoI/BamHI-digested
pcDNA3.1/Myc-His(
) A: for N-(1-120), FX29
(5'-ATCCTCGAGCGATCATGGCCAATGTCCAC-3') and RB360 (5'-ATCGGATCCGAATTCATCATGGTGATC-3'); for N-(1-112), FX29 and RB336 (5'-ATCGGATCCGTTAGACAGCTCCCCCAT-3'); for N-(1-100), FX29 and RB300 (5'-ATCGGATCCTCTCAGCTGTAGCTCCCT-3'); for N-(1-71), FX29 and RB213 (5'-ATCGGATCCGTCATTCATCTGCCTGTT-3'); for N-(1-20), FX29 and RB60 (5'-ATCGGATCCTTCCTGTCCATTCTGCAG-3'); for N-(41-124), FX121
(5'-ATCCTCGAGACCATGCACAACCATAACCACAAC-3') and RB27
(5'-ATCGGATCCAGGCATAAGGCAGAATTC-3'); for N-(81-124), FX241
(5'-ATCCTCGAGACCATGGAAATGTTCATGGAGGAG-3') and RB27; for N-(101-124),
FX301 (5'-ATCCTCGAGACCATGAATTGTCTACGCATCCTT-3') and RB27; for
N-(41-71), FX121 and RB213; for FLAG-tagged N(WT), FX29, and
RBFLAG
(5'-CGCGGATCCTCACTTATCGTCGTCATCCTTGTAATCAGGCATAAGGCAGAATTC-3').
Point mutants for NADE were constructed by PCR amplification of
NADE coding sequences using oligonucleotide pairs as
described below, followed by digesting the resulting PCR product with
DpnI: for N(L99A) and GFP-N(L99A), in which Leu-99 is
replaced with Ala, F-L99A (5'-AGGGAGCTACAGGCGAGAAATTGTCTA-3'), and
R-L99A (5'-TAGACAATTTCTCGCCTGTAGCTCCCT-3'); for N(L94A/L97A/L99A) and
GFP-N(L94A/L97A/L99A), in which Leu-94, Leu-97, and Leu-99 are replaced
with Ala, F-L97A (5'-AAAGCTTAGGGAGGCACAGCTGAGAAA-3'), R-L97A
(5'-TTTCTCAGCTGTGCCTCCCTAAGCTTT-3') and F-L97A/L99A
(5'-AGGGAGGCACAGGCGAGAAATTGTCTA-3'), R-L97A/L99A
(5'-TAGACAATTTCTCGCCTGTGCCTCCCT-3') and F-L94A/L97A (5'-ATCCGGAGAAAGGCTAGGGAGGCACA-3'), R-L94A/L97A
(5'-TGTGCCTCCCTAGCCTTTCTCCGGAT-3').
Expression plasmids encoding fusion proteins of green fluorescence
protein (GFP) and NADE proteins were constructed as follows: GFP
cDNA was PCR-amplified from pEGFP-N2 (CLONTECH,
Palo Alto, CA) by using the primer pair
5'-CTAGCTAGCATCATGGTGAGCAAGGGCGAG-3' and
5'-CCGCTCGAGTCTTGTACAGCTCGTCCAT-3'. The product was cloned into the
NheI and XhoI sites of
pcDNA3.1/Myc-His(
)A/mNADE. Expression plasmids for glutathione
S-transferase (GST)-fused p75NTR proteins have been
described previously (28).
pVP16/N(WT) and pVP16/N(L94A/L97A/L99A) were constructed by PCR
amplification of N(WT) and N(L94A/L97A/L99A), respectively, using
oligonucleotide pairs as shown, digesting the resulting fragments with
BamHI/NotI, and ligating the fragments into
BamHI/NotI-digested pVP16: forward primer
(5'-GGGATCCTAATGGCCAATGTCCACCAGGAA-3') and reverse primer
(5'-ATAGTTTAGCGGCCGCAATCAAGGCATAAGGCA-3'). pBTM116/N(WT) was
constructed by PCR amplification of N(WT) using oligonucleotide pairs
as shown, digesting the resulting fragments with
BamHI/SalI, and ligating the fragments into
BamHI/SalI-digested BTM116: forward primer
(5'-GGGATCCTAATGGCCAATGTCCACCAGGAA-3') and reverse primer (5'-TGCGGTCGACGCTAAGGCATAAGGCAGAA-3'). pBTM116/p75DD was
constructed by PCR amplification of pcDNA3/p75NTR using
oligonucleotide pairs as shown, digesting the resulting fragments with
EcoRI/SalI and ligating the fragments into
EcoRI/SalI-digested BTM116: forward primer
(5'-CGGAATTCAAGGGTGATGGCAACCTC-3') and reverse primer
(5'-GCGTCGACTCAGTAACCCAGCTCGCCTGC-3').
Recombinant Adenovirus Construction--
Adenoviral vectors were
constructed using the Adeno-X Expression system
(CLONTECH) according to the protocol recommended by the manufacturer. pShuttle/Myc-GFP, pShuttle/Myc-N(WT), and
pShuttle/Myc-N-(81-124) were constructed by digesting the
pcDNA3.1/Myc-His(
)A/GFP, pcDNA3.1/Myc-His(
)A/N(WT), and
pcDNA3.1/Myc-His(
)A/N-(81-124) with
NheI/AflII, and ligating the resulting fragments
into the NheI/AflII sites of the pShuttle vector.
pAdeno-X/Myc-GFP, pAdeno-X/Myc-N(WT), and pAdeno-X/Myc-N-(81-124) were
constructed by digesting pShuttle constructs with
PI-SceI/I-CeuI and ligating the
resulting fragments into the
PI-SceI/I-CeuI sites of the pAdeno-X
adenoviral vector. Recombinant adenoviral plasmids were packaged into
infectious adenoviral particles by transfecting human embryonic kidney
(HEK) 293 cells. The adenoviral particles were propagated in HEK293
cells and purified on cesium chloride gradients. Recombinant
adenoviruses were screened for expression of the introduced genes by
fluorescent microscopy and/or Western blot analysis.
Adenoviral-mediated Gene Transfer to
Oligodendrocytes--
Adenoviral infection was performed on
oligodendrocytes that were cultured for 7 days in Basal Medium Eagle
(BME), which is described under "Cell Culture and Transfection."
Cells were infected with 4-10 plaque-forming units/cell of adenovirus
in BME. After incubation for 6 h at 37 °C, cultures were
replaced with fresh BME for 18 h. For the apoptosis assay,
infected oligodendrocytes were treated with 100 ng/ml NGF.
Reagents and
Antibodies--
N-Acetyl-Leu-Leu-norleucinal (ALLN), NGF,
leptomycin B (LMB), and the anti-FLAG monoclonal antibody were obtained
from Sigma Chemical Co. (St. Louis, MO). Anti-rabbit IgG-Alexa Fluor
568, and anti-mouse IgG-Alexa Fluor 350 were obtained from Molecular Probes (Eugene, OR). The anti-
-NADE polyclonal antibody was prepared as described previously (28). The anti-O1 mouse monoclonal antibody was
a kind gift from Dr. S. Pfeiffer. The anti-myc polyclonal antibody was
obtained from MBL International Corp. (Watertown, MA). The anti-myc
monoclonal antibody was obtained from BIOMOL Research Laboratories,
Inc. (Plymouth Meeting, PA).
Cell Culture and Transfection--
293T cells were obtained from
the American Type Culture Collection; 293T cells were maintained in
DMEM supplemented with 10% fetal bovine serum. For transfection, 293T
cells (1.5 × 106 per 100-mm dish) were transiently
transfected with 25 µg of DNA using the calcium phosphate method in
DMEM supplemented with 10% fetal bovine serum and cultured for 10 h. After withdrawing the serum, the cells were treated with 100 ng/ml
NGF for 36 h. Oligodendrocytes were prepared as described
previously (36). Mixed glial cultures were prepared from P2-rat cortex.
After plating on poly-D-lysine-coated 75-cm2
flasks, cultures were grown at 37 °C in a humidified incubator with
5% CO2 for 7 days. Oligodendrocytic cultures were
typically preplated and grown for 24 h in NM15 media (minimal
essential medium supplemented with 15% FCS, 6 mg/ml glucose, 10 units/ml penicillin, and 10 mg/ml streptomycin). Cultures were then
switched to oligodendrocyte differentiation media, containing
BME:Ham's F-12 (1:1 v/v) supplemented with 6 mg/ml
D-glucose, 100 units/ml penicillin, 100 µg/ml
streptomycin, 100 µg/ml transferrin, 25 µg/ml insulin, 20 nM progesterone, 60 µM putrescine, 30 nM selenium, 6.6 mM glutamine, and 0.5 µM thyroxine.
Subcellular Localization Analysis--
293T cells were plated
onto glass coverslips and transfected with GFP-containing constructs.
At 24 h after transfection, cells were fixed with 3.7%
paraformaldehyde, washed with phosphate-buffered saline (PBS),
and stained with Hoechst 33342 to visualize the nucleus. The images
of representative fields were captured on a fluorescence microscopy
EFD-3 (Nikon) and recorded with a SPOT-RT digital charge-coupled
device camera (Diagnostic Instruments).
Subcellular Fractionation--
Subcellular fractionation was
performed as described previously (37). Transfected 293T cells were
washed in PBS. Half of the cells were used for preparation of
cytoplasmic and nuclear extracts, respectively. For preparation of
cytoplasmic extracts, the cells were resuspended in 300 µl of buffer
A (50 mM HEPES, pH 7.4, 50 mM KCl, 5 mM EDTA, 2 mM MgCl2, 0.1 mM dithiothreitol, 20 µM leupeptin, 10 µg/ml pepstatin A, 1 mM PMSF, and 1 mM
benzamidine), and allowed to swell by incubation for 10 min on ice. The
cells were gently homogenized with a Dounce homogenizer. Small aliquots of the lysate were taken and stained with trypan blue to determine the
progression of cell lysis. Homogenization was continued until more than
95% of the cells were broken. After centrifugation at 1500 × g, the resultant supernatant was carefully removed and supplemented with 60 µl of 6-fold concentrated standard reducing sample buffer. For preparation of nuclei, cells were incubated on ice
for 10 min in buffer B (10 mM HEPES, pH 7.4, 10 mM KCl, 2 mM MgCl2, 0.1 mM dithiothreitol, 20 µM leupeptin, 10 µg/ml pepstatin A, 1 mM PMSF, and 1 mM
benzamidine) and homogenized as described for the preparation of
cytoplasmic extracts. When more than 95% of the cells were lysed, the
salt concentration was adjusted to 150 mM, and the
suspension was layered over 20% (w/v) sucrose in buffer B and
centrifuged at 800 × g. The nuclei were washed, resuspended in 300 µl of buffer B, and supplemented with 60 µl of
6-fold concentrated standard reducing sample buffer.
In Vitro Binding Assay--
In vitro translated
[35S]methionine-labeled proteins were generated with the
TnT-coupled reticulocyte lysate system (Promega, Madison, WI). Binding
assays were performed as described previously (28).
Co-immunoprecipitation and Western Blot--
The transfected
293T cells were lysed in a buffer containing 20 mM
Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.2%
Nonidet P-40, 1 mM PMSF, 1 mM benzamidine, 50 µg/ml leupeptin, 7 µg/ml pepstatin A, and 25 µM
ALLN). The lysates were then centrifuged at 15,000 × g
for 15 min at 4 °C. Myc was then immunoprecipitated from the
resulting supernatants with 0.8 µg of an anti-Myc monoclonal antibody
coupled to CNBr-activated Sepharose 4B (Amersham Biosciences, Inc.,
Uppsala, Sweden). The immune complexes were then subjected to SDS-PAGE
on 12.5% polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). The membrane was blocked
for 5 h at room temperature in blocking buffer containing 10%
skim milk and 0.1% NaN3 in PBS. FLAG-tagged constructs
were detected by Western blotting with an anti-FLAG monoclonal antibody and visualized with the ENHANCE chemiluminescence system (Amersham Biosciences, Inc.).
Immunocytochemistry--
The O1 mouse monoclonal antibody was
used to identify oligodendrocytes. Cells were gently washed with PBS,
and viable cells were incubated with the O1 antibody for 30 min at room
temperature (1:100 dilution in Hanks' balanced salt solution buffer
containing 3% bovine serum albumin and 3% fetal calf serum). For
double-staining, cells were then fixed with 3.7% paraformaldehyde for
30 min at room temperature, permeabilized with 0.1% sodium citrate
containing 0.1% Triton X-100 for 2 min on ice, and processed for TUNEL
as described below. Cells were incubated with the anti-Myc polyclonal antibody in PBS containing 1% bovine serum albumin and 1% normal goat
serum (Sigma) for 1 h at room temperature. After several rinses
with PBS, cells were incubated with the anti-rabbit IgG-Alexa Fluor 568 and anti-mouse IgG-Alexa Fluor 350 at room temperature for 30 min.
These antibodies were used at 1:100 dilutions in PBS supplemented with
0.5 M NaCl and 1% normal goat serum.
TUNEL Assay and DAPI Staining--
In situ detection
of apoptotic oligodendrocytes was performed by using a TUNEL method
(38). After incubation with the O1 antibody, oligodendrocytes were
fixed and permeabilized, as described above. After several rinses,
samples were processed for TUNEL using the in situ cell
death detection assay according to the protocol suggested by the
manufacturer (MBL International Corp.). In some experiments, Alexa
568-dUTP (Molecular Probes) was used instead of FITC·dUTP as a
substrate for the TUNEL reaction. Double-stained cells were visualized
by fluorescence microscopy EFD-3 (Nikon) and recorded with a SPOT-RT
digital charge-coupled device camera (Diagnostic Instruments).
Apoptotic cells were determined by counting the percentage of
TUNEL-positive cells among O1-positive cells in four fields across the
coverslip. At least 400 cells were counted for each condition.
The transfected 293T cells were washed with PBS, fixed in 3.7%
paraformaldehyde, and stained with 50 µg/ml DAPI. A minimum of 400 cells was analyzed by fluorescence microscopy in each sample. Within
this group, the number of cells that had the nuclear morphology typical
of apoptosis was determined in each sample.
Yeast Two-hybrid Analysis--
Analysis of protein·protein
interactions by yeast two-hybrid system was performed essentially as
described by Vojtek et al. (39). The cDNAs encoding a
full-length NADE and a death domain of p75NTR were subcloned
into pBTM116 (pBTM116/N(WT) and pBTM116/p75DD). Each plasmid was then
transformed into the L40 yeast strain (Mata trp1 leu2 his3 ade2
LYS2::(LexAop)4-HIS3
URA::(LexAop)8-LacZ), and the yeast cells were propagated with appropriate selection. The L40
yeast cells containing pBTM116/N(WT) or pBTM116/p75DD were transformed
with pVP16/N(WT) or pVP16/N(L94A/L97A/L99A). Histidine prototrophy was
determined on plates containing 5 mM 3-aminotriazole to
detect the association of NADE or p75DD.
 |
RESULTS |
Characterization of NADE Deletion Mutants for Apoptosis--
To
determine the structural elements of NADE that are required for
apoptosis, we generated a series of NADE deletion mutants and point
mutations of NES sequence, as shown in Fig.
1 (A and B). To
analyze p75NTR·NADE-mediated apoptosis, we assessed nuclear morphology by DAPI staining. 293T cells were transiently transfected with pcDNA3.1/Myc-His/mNADE (N(WT)) or/and pcDNA3p75NTR, then incubated in the presence or absence of 100 ng/ml NGF. Cells
co-transfected with N(WT) and p75NTR displayed the typical
morphological characteristics of apoptosis, including nuclear
condensation and fragmentation, in response to NGF treatment (Fig.
2A). In contrast, cells singly transfected with either N(WT) or p75NTR displayed a normal nuclear morphology, similar to that in cells transfected with the control vector alone. When apoptotic cells were scored based on morphological criteria, ~45% of 293T cells that were co-transfected with both N(WT) and p75NTR displayed apoptotic morphology in response to NGF
(Fig. 2B). In contrast, only about 6% of cells transfected with the empty vector, N(WT) alone, or p75NTR alone exhibited apoptotic
morphology.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of NADE
mutants. A, deletion mutants of NADE. The domain
structure of full-length mouse NADE (N(WT)) is shown at the
top, and amino acid numbers are listed above. The
nuclear export signal (NES) (90-100) and ubiquitin sequence
(US) (91-112) domains are indicated by black and
cross-hatching, respectively. B, point mutations
in the NES of NADE. The NES sequences for wild-type and NES mutants are
shown.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
NGF-dependent regulation of
p75NTR·NADE-induced apoptosis in 293T cells. A,
morphological analysis in 293T cells. Cells were transiently
transfected with pcDNA3/rat-p75NTR and/or
pcDNA3.1/Myc-His( )A/N(WT) and cultured for 10 h. After
withdrawing the serum, cells were treated in the presence (+) or
absence ( ) of 100 ng/ml NGF for 36 h. Cells were fixed with
3.7% paraformaldehyde and nuclear morphology was analyzed by DAPI
staining, as described under "Experimental Procedures."
B, overall percentage of apoptotic cells as determined by
DAPI staining. Fluorescence microscopy was used to determine the number
of cells with nuclear morphology typical of apoptosis from a total of
at least 400 cells in each sample. The data are expressed as the
average percentage of apoptotic cells ± S. D. from four
separate experiments.
|
|
Various truncation mutants of NADE were co-transfected into 293T cells
with or without p75NTR. The cells were then treated with NGF, and the
percentage of apoptotic cells were evaluated. As shown in Fig.
3 and Table
I, we found that two N-terminal deletion
mutants, N-(81-124) and N-(101-124), failed to induce apoptosis,
whereas deletion of the N-terminal 40 amino acids (N-(41-124)) did not
affect apoptosis. The ability to induce apoptosis was retained in the
C-terminal deletion mutant, N-(1-71) but not in N-(1-20), a shorter
C-terminal deletion mutant. Furthermore, expression of a minimal region
of NADE containing only residues 41-71 (N-(41-71)) was sufficient to
induce apoptosis. In cells expressing wild-type NADE (N(WT)), the
presence of p75NTR was required to induce apoptosis. In contrast,
expression of N-(1-71), which lacks the p75NTR-binding domain
(residues 81-106), retained its pro-apoptotic function even in the
absence of p75NTR expression. Similar results were obtained with the
N-(41-71) and N-(1-100) mutants, which failed to associate with
p75NTR but still induced apoptosis. On the other hand, expression of
N-(1-120), N-(1-112), and N-(41-124), each of which can associate
with p75NTR, induced apoptosis in an NGF-dependent manner.
Thus, the C-terminal amino acid residues (72-112), designated as the
regulatory domain of NADE, are essential for NGF-dependent regulation of apoptosis.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Mapping analysis of NADE for apoptosis.
The indicated constructs were transiently transfected into 293T cells
with (open bars) or without (black bars) p75NTR,
as described under "Experimental Procedures." Cells were fixed with
3.7% paraformaldehyde and nuclear morphology was analyzed by DAPI
staining. The data are expressed as the average percentage of apoptotic
cells among the total number of cells counted ± S.D.
(n = 4).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Summary of cell death assay and the association with p75NTR for NADE
and its mutants
In each cell death assay, + represents apoptotic cells that are scored
more than 30% of 293T cells; represents apoptotic cells that are
scored more than 10% of 293T cells.
|
|
NADE NES Is Necessary for Self-association, Interaction with
p75NTR, and Apoptosis--
In our previous report, we observed that
the C-terminal residues of NADE between amino acids 90-100 conform to
the consensus sequence for a functional NES motif, as indicated by the
similarity of this region to other known NESs, shown in Fig.
4A. We demonstrated that
wild-type NADE, which has an intact NES, was localized in the
cytoplasm, but that the GFP-NES mutants (L94A and L97A) were retained
in the nucleus (28). Because the NES is localized within the regulatory
domain of NADE and partially includes the p75NTR-binding domain at
residues 81-106, we hypothesized that the NES may play a role in the
regulation of p75NTR·NADE-induced apoptosis. To more specifically
analyze the function of this motif, we constructed two NADE point
mutations. In N(L99A), a single leucine was mutated to alanine, and in
N(L94A/L97A/L99A) three leucines were mutated to alanines at residues
94, 97, and 99 within the NES (Fig. 1B). Expression and
subcellular distribution of GFP-NADE fusion proteins derived from these
mutants were visualized in 293T cells by fluorescence microscopy.
GFP-N(L94A/L97A/L99A) was observed both in the nucleus and in the
cytoplasm (Fig. 4B), whereas wild-type NADE and N(L99A) were
localized exclusively in the cytoplasm.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of NADE NES function.
A, NADE contains a conserved Rev-like NES motif.
Mouse NADE is aligned with homologous NADE sequences from rat and
human, and with the NES of PKI, HIV, Rev, MDM2 and MAPKK. B,
subcellular localization of NES mutants in 293T cells. Cells were
transfected with GFP-vector, GFP-N(WT), GFP-N(L99A), or
GFP-N(L94A/L97A/L99A), as indicated. Hoechst 33342 was used to
visualize the nucleus, and subcellular localization was determined as
described under "Experimental Procedures." C, effect of
leptomycin B (LMB). 293T cells transiently expressing GFP-N(WT) or
GFP-N(L94A/L97A/L99A) were treated with or without 5 ng/ml LMB. After 3 or 12 h, cells were analyzed by fluorescent microscopy.
D, subcellular distribution of NADE. 293T cells transiently
expressing N(WT) or N(L94A/L97A/L99A) were treated with or without 5 ng/ml LMB. After 12 h, cells were homogenized and separated into
cytoplasmic (C) and nuclear (N) fractions. The
distribution of N(WT) or N(L94A/L97A/L99A) was analyzed by Western
blotting with an anti-Myc antibody.
|
|
To determine whether the cytoplasmic localization of wild-type NADE is
predominantly caused by the presence of a leucine-rich NES,
GFP-N(WT)-transfected 293T cells were treated with 5 ng/ml leptomycin B
(LMB). LMB has been shown to bind directly and irreversibly to CRM1 and
inhibits NES-mediated active nuclear export (40). Within 3 h of
LMB treatment, GFP-N(WT) was observed both in the nucleus and the
cytoplasm, but GFP-N(WT) did not accumulate in the nucleus (Fig.
4C). After long term treatment with LMB (12 h), GFP-N(WT)
was still distributed diffusely all over the cell. In contrast, the
distribution of N(L94A/L97A/L99A) was not affected with LMB treatment
(Fig. 4C). To verify these results, we performed subcellular
fractionation and detected the distribution of N(WT) and
N(L94A/L97A/L99A) using Western blotting. Consistent with the
subcellular localization results of GFP constructs, Myc-N(WT) was
detected in the cytoplasmic fraction but not in the nuclear fraction
without LMB treatment and partially moved to the nuclear fraction from
the cytoplasmic fraction after 12 h of LMB treatment (Fig.
4D, left panel). In contrast, the distribution of
N(L94A/L97A/L99A), which was detected both in the nuclear and
cytoplasmic fractions without LMB treatment, did not change following
LMB treatment (Fig. 4D, right panel).
We previously reported that in 293T, PC12, and nnr5 cells transfected
with wild-type NADE, two bands (22 and 44 kDa) were detected by Western
blotting when SDS-PAGE was performed under reducing conditions (28).
These bands correspond to the monomeric and dimeric forms of NADE,
respectively. To confirm the self-association of NADE and to identify
the region required for self-association, both FLAG-tagged NADE (N(WT))
and myc-tagged NADE mutants were transiently transfected into 293T
cells. Immunoprecipitation of myc-tagged NADE mutants from cell
extracts with an anti-myc antibody co-immunoprecipitated FLAG-tagged
N(WT), as determined by immunoblotting with an anti-FLAG antibody. This
experiment showed that N-(1-112) and N-(81-124) retained their
ability to interact with N(WT) (Fig. 5A). In contrast, N-(1-100)
failed to associate with N(WT), indicating that the region between
residues 81-112, which includes the NES, is critical for
self-association. We next transiently co-transfected 293T cells with
FLAG-tagged N(WT) and myc-tagged N(L99A) or N(L94A/L97A/L99A) (Fig.
5B). These experiments showed that N(L94A/L97A/L99A) does not dimerize with wild-type NADE, although N(L99A) dimerized with wild-type NADE under reducing conditions. Three of the key hydrophobic residues of NES, Leu-94, Leu-97, and Leu-99, reside within the p75NTR
binding domain of NADE, suggesting that these NES mutations may also be
affecting the interaction of p75NTR with NADE. We therefore performed
in vitro binding assays using GST fusion proteins to
determine whether proteins containing these point mutations are able to
interact with p75NTR(ICD). As shown in Fig. 5C, the N(L99A)
single mutant associated with the p75NTR(ICD), however, the
N(L94A/L97A/L99A) triple mutant did not. In addition, a N(L94A/L97A) double mutant associated with p75NTR(ICD), albeit much less efficiently than did wild-type NADE (data not shown). To verify these results, we
performed interaction analysis of N(L94A/L97A/L99A) with N(WT) or the
death domain of p75NTR (p75DD) in the yeast two-hybrid system.
Consistent with the immunoprecipitation or the in vitro binding assay results, N(WT) self-associated with N(WT) or associated with p75DD, but N(L94A/L97A/L99A) did not (Fig. 5D). These
results suggest that the NES is necessary for self-association of NADE and that the association or dissociation of NADE monomers may be linked
to the regulation of its nuclear export.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 5.
Self-association of NADE. A,
FLAG- and myc-tagged N(WT) or various NADE mutants were expressed in
293T cells as indicated in the top panel. 24 h after
transfection, cell lysates myc-tagged proteins were immunoprecipitated
from cell lysates, as described under "Experimental Procedures."
Samples were then subjected to immunoblotting with an anti-FLAG
antibody (upper panel). Cleared whole cell lysates were also
immunoblotted with anti-FLAG (middle panel) and anti-myc
(lower panel) antibodies. Asterisks indicate IgG
bands. B, mutation of leucines in NES disrupts NADE
self-association. 293T cells were transfected with plasmids producing
FLAG-tagged N(WT) and Myc-tagged N(WT) or indicated NES mutants shown
at top panel. Asterisks indicate IgG bands.
C, interaction of wild-type and NES mutants with p75NTR. A
GST fusion protein containing the cytoplasmic region of p75NTR was
incubated with either wild-type or mutant NADE that had been translated
in vitro and labeled with [35S]methionine.
35S-Labeled bound complexes were precipitated as described
previously (28). D, self-association of NADE in yeast. L40
yeast cells were transformed with pBTM116/N(WT), or pBTM116/p75DD, and
indicated NADE constructs in pVP16. Yeast transformants were streaked
on solid growth media with (+His) or without
( His) histidine. Growth of colonies on His-free plates is
an indication that two proteins interact in yeast. p75DD, a
death domain of p75NTR.
|
|
We next evaluated apoptosis in cells expressing the various NES point
mutants of NADE (Fig. 6). This analysis
showed that cells expressing the N(L94A/L97A/L99A) triple mutant
failed to undergo apoptosis, whereas cells expressing the N(L99A)
single mutant did undergo apoptosis. Thus, the NES motif of NADE is
crucial not only for nuclear export, self-association, and
interaction of NADE with p75NTR but is also required for
NGF-dependent p75NTR·NADE-induced apoptosis.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of NES mutations on apoptosis.
Various NADE constructs were co-transfected with p75NTR into 293T
cells, as indicated. Cells were fixed with 3.7% paraformaldehyde, and
nuclear morphology was analyzed by DAPI staining. Data shown are
expressed as the average percentage of apoptotic cells among the total
number of cells counted ± S. D. (n = 4).
|
|
Dominant Negative Effect of N-(81-124) on NGF-induced Apoptosis in
Oligodendrocytes--
NGF treatment induces apoptosis in
terminally differentiated primary oligodendrocytes expressing high
levels of p75NTR. For this reason, we used oligodendrocytes to
characterize the mechanism by which NADE promotes a death signal
through p75NTR. Interestingly, after NGF treatment, the expression of
NADE mRNA and protein was increased in oligodendrocytes
(28). To evaluate the NADE-mediated events that induce apoptosis in
oligodendrocytes, we introduced the N-(81-124) NADE mutant into mature
oligodendrocytes. The protein encoded by this construct does associate
with p75NTR, but lacks a pro-apoptotic region (Table I).
Oligodendrocytes were infected with a recombinant adenovirus carrying
the myc-tagged NADE cDNA. As a control, other
oligodendrocytes were infected with an adenoviral vector containing
myc-tagged GFP. Typically, more than 90% of oligodendrocytes were
infected with adenovirus, as assessed by immunofluorescence microscopy.
As shown in Fig. 7 (A and
B), oligodendrocytes were identified as blue signals by
staining with an anti-O1 monoclonal antibody and an Alexa Fluor 350 anti-mouse IgG secondary antibody. Green signals were
detected in control cells expressing GFP, and TUNEL-positive
oligodendrocytes were visualized with red signals using
Alexa 568·dUTP as a substrate (Fig. 7, A and
B). In oligodendrocytes expressing GFP, the
percentage of TUNEL-positive cells was 68.1% (n = 4)
and 10.5% (n = 4), in the presence and absence of NGF, respectively (Fig. 7C). The percentage of TUNEL-positive
cells among those that were not infected with adenovirus was not
significantly affected by NGF treatment (Fig. 7C).
Transfectants expressing myc-tagged N-(81-124) and N(WT) exhibited
red fluorescence, and TUNEL-positive oligodendrocytes
exhibited green fluorescence with FITC·dUTP used as a
substrate (Fig. 7B). In the presence of NGF, 25.6% of cells
expressing N-(81-124) were TUNEL-positive, whereas 72.1% of cells
expressing N(WT) were TUNEL-positive (n = 4 in each
group). Expression of N-(81-124) inhibited NGF-induced apoptosis in
oligodendrocytes (Fig. 7C). Thus, N-(81-124) appears to
have a dominant negative effect on NGF-induced apoptosis in
oligodendrocytes.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Dominant negative effect of N-(81-124) on
NGF-induced apoptosis in oligodendrocytes. Differentiated
oligodendrocytes were infected with an adenovirus carrying GFP,
N-(81-124), and N(WT). Infected cells were treated with 100 ng/ml NGF
for 18 h. Oligodendrocytes were visualized with an anti-O1
monoclonal antibody and an Alexa 350 anti-mouse IgG second antibody,
resulting in a blue signal. A, GFP expression was
visualized as a green signal. TUNEL-positive
oligodendrocytes were identified by red fluorescence, using
Alexa 568-dUTP as a substrate of TUNEL reaction. The superimposed
arrows indicate positive signals of GFP and TUNEL.
B, cells expressing myc-tagged N-(81-124) and N(WT) are
visualized as red fluorescence with an anti-myc polyclonal
antibody and an Alexa 568-anti-rabbit IgG second antibody.
TUNEL-positive oligodendrocytes are visualized as green
fluorescence using FITC·dUTP as a substrate of TUNEL reaction.
The superimposed arrows indicate positive signals of
myc-tagged proteins and TUNEL. C, effect of N(WT)
versus N-(81-124) NADE on NGF-induced apoptosis in
oligodendrocytes. Data shown are expressed as the average percentage of
TUNEL-positive cells among the total number of cells counted ± S.D. (n = 4).
|
|
 |
DISCUSSION |
The recent identification of distinct classes of
receptor-associated signal transducers has provided insight into how
members of the TNF receptor superfamily initiate downstream signaling events (41). The death domain is essential for the transduction of
death signals elicited by ligands in the TNFR/Fas family, which belong
to a superfamily of receptors that includes p75NTR. Several downstream
targets of the TNFR and Fas death domains (subtype 1) have been
identified (42). These proteins also contain death domain sequences,
suggesting that there is a signaling mechanism triggered by the
association of death domain-containing proteins, including
self-association of death domains such as MORT1/FADD (43).
However, the functional role of the downstream targets of the p75NTR
death domain (subtype 2), including death-associated protein
kinase, ankyrin, and NF-
B p100 and p105 is still unclear. Structural
analysis by NMR suggested that there is a potential site within the
death domain of p75NTR that may interact with downstream targets in a
ligand-dependent manner (44). We have reported that NADE
associates with the death domain of p75NTR in an
NGF-dependent manner and that this association induces
apoptosis (28). To better understand the mechanism by which NADE
mediates cell death, we have used mutational analysis to define the
regions that correlate with the cellular functions of NADE. These
studies revealed that NADE has a structure composed of modular regions that mediate specific functions.
Deletion mapping was the first approach we used to delineate the
regions involved in NADE function. A schematic overview of the
structural regions of NADE that were correlated with specific cellular
functions is shown in Fig. 8. Expression
of a minimal region of NADE-(41-71) was termed the pro-apoptotic
region, because this fragment was sufficient to induce apoptosis even
in the absence of NGF. In previous studies, we demonstrated that
p75NTR·NADE-induced apoptosis was NGF-dependent in 293T
cells after the interaction of NADE with p75NTR (28). Further analysis
showed that apoptosis occurred in an NGF-dependent manner
in cells expressing mutants in which both the pro-apoptotic and the
p75NTR-binding regions were conserved. On the other hand, cells
expressing mutants containing the pro-apoptotic region but not the
p75NTR-binding region underwent apoptosis even in the absence of
p75NTR. These results indicate that the C-terminal region regulates the
pro-apoptotic region in response to NGF. This region (72-112) is
termed the regulatory region, and includes the p75NTR-binding
region.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 8.
Summary of the structure-function
relationship of various regions of NADE. The structure of
full-length mouse NADE (N(WT)) is shown at the top, and
amino acid numbers are indicated above. The nuclear export
signal (NES) is localized at amino acids 90-100, and the
ubiquitin sequence (US) is localized at 91-112. The
pro-apoptotic region resides within 41-71. The regulatory region
resides between 72 and 112 and contains the p75NTR-binding region
(81-106) and the self-association region (81-112). The 14-3-3 binding
region is located between 81 and 124.
|
|
We also generated a series of point mutations within the NES motif of
NADE, because this subregion (90-100) is located within the regulatory
region of NADE (Figs. 4A and 8). We constructed several
point mutants, including N(L99A) and N(L94A/L97A/L99A), because
analogous mutations in other NES-containing proteins have been reported
to prevent nuclear export (45, 46). Expression of N(L94A/L97A/L99A)
decreased the efficiency of nuclear export (Fig. 4C).
Moreover, LMB inhibited export of N(WT) from nucleus (Fig.
4C), suggesting that NADE is exported from the nucleus by a
mechanism involving an LMB-sensitive NES between amino acids 90 and
100. These NES-mutational studies also showed that expression of
N(L94A/L97A/L99A) decreased the interaction of NADE with p75NTR and
self-association, suggesting that the NES motif of NADE plays a crucial
role in each of these functions.
Interestingly, the regulatory region of NADE also associates with
14-3-3 proteins (32). Some 14-3-3 binding proteins have a functional
nuclear localization signal (NLS)/NES that lies adjacent to the site of
14-3-3 binding (47-49). The N(L94A/L97A/L99A) triple mutant failed to
associate with 14-3-3
, suggesting that the NES motif of NADE might
be important for 14-3-3 binding (data not shown). Thus, the NADE NES
triple mutant lost p75NTR- and 14-3-3-binding activity as well as
self-associating activity. Taken together, these findings suggest that
the NADE NES might be an important platform for switching the
conformation of NADE to regulate pro-apoptotic activity.
NADE has at least two homologues, Bex1 and Bex2, that are highly
homologous to each other at amino acid level (29). In the sublocalization analysis using immunocytochemistry, human Bex1 is
diffusely localized in both the nucleus and the cytoplasm, suggesting
that Bex1 does not have a functional NES (data not shown). Indeed, in
the region corresponding to NADE NES in human Bex1 and Bex2
(RQLMEKLREKQLS),
the third leucine is replaced with lysine in the NES motif. Moreover, human Bex1 failed to dimerize, associate with p75NTR and NADE, and to
induce p75NTR-dependent apoptosis in 293T cells (data not shown), suggesting that Bex1 is not involved in p75NTR signaling. Although the regions, corresponding to the NADE-regulatory
region in human Bex1 and Bex2, are identical to each other, further
investigation is necessary to analyze hBex2 on nuclear export, p75NTR
binding, oligomerization, and p75NTR-dependent apoptosis.
NGF-induced apoptosis has been shown to occur in primary cultured
oligodendrocytes (20, 36). In a previous study, we proposed that NADE
is involved in this signaling pathway, because the expression of
NADE mRNA and protein were increased by NGF in
oligodendrocytes (28). NADE expression was also increased in response
to zinc-induced apoptosis in rat cortical neurons (30). Because
zinc-induced apoptosis was blocked by an antisense oligonucleotide of
NADE, NADE appears to be involved in this type apoptosis in
neurons (30). In the present report, we analyzed the effects of
expressing various NADE mutants on NGF-induced apoptosis in
oligodendrocytes. Expression of N-(81-124) inhibited NGF-induced
apoptosis in oligodendrocytes, suggesting that N-(81-124) has a
dominant negative effect on NGF/p75NTR-mediated apoptosis. Thus, the
N-terminal region of NADE, which contains the pro-apoptotic region, may
have a functional motif that transduces the apoptotic signal.
In our previous report, we showed that 14-3-3
is involved in
NGF-induced apoptosis in oligodendrocytes (31). We also observed that
14-3-3
can associate with N-(81-124). However, co-expression of
N-(81-124) and 14-3-3
did not induce
NGF/p75NTR-dependent apoptosis in HEK293 cells (data not
shown). These findings suggest that the recruitment of 14-3-3
to the
p75NTR·NADE complex is necessary but not sufficient to mediate
apoptosis through p75NTR. We hypothesize that, after NADE is recruited
to the p75NTR(ICD) in response to NGF, the NADE protein undergoes a
conformational change that exposes the pro-apoptotic region to as yet
unknown signaling elements that mediate the downstream
apoptosis-signaling pathway. In future studies, it will be of interest
to identify the specific downstream molecules targeted by this
pro-apoptotic region.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant R01-GM55147 (to T. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: Dept. of Otolaryngology, School of Medicine,
Kitasato University, Kanagawa 228-8555, Japan.
To whom correspondence should be addressed: Division of
Molecular Oncology, Dept. of Otolaryngology/Head & Neck Surgery and Pathology, College of Physicians & Surgeons, Columbia University, 630 W. 168th St., P&S 11-451, New York, NY 10032. Tel.: 212-305-1701; Fax:
212-305-1736; E-mail: ts174@columbia.edu.
Published, JBC Papers in Press, February 5, 2002, DOI 10.1074/jbc.M106342200
 |
ABBREVIATIONS |
The abbreviations used are:
NGF, nerve growth
factor;
ICD, intracellular domain;
p75NTR, p75 neurotrophin receptor;
GFP, green fluorescence protein;
PBS, phosphate-buffered saline;
GST, glutathione S-transferase;
FITC, fluorescein isothiocyanate;
DMEM, Dulbecco's modified Eagle's medium;
DAPI, 4,6-diamidino-2-phenylindole;
TrkA, tyrosine kinase receptor;
MAP, mitogen-activated protein;
MAPKK, MAP kinase kinase;
TNF, tumor
necrosis factor;
TRAF, TNF receptor-associated factor;
ICD, intracellular domain;
NADE, p75NTR-associated cell death executor;
NES, nuclear export signal;
WT, wild-type;
HEK, human embryonic kidney;
BME, Basal Medium Eagle;
ALLN, N-acetyl-Leu-Leu-norleucinal;
LMB, leptomycin B;
PMSF, phenylmethylsulfonyl fluoride;
TUNEL, terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling;
MORT1, mediator of receptor-induced toxicity;
FADD, Fas-associating death
domain protein.
 |
REFERENCES |
| 1.
|
Raff, M. C.,
Barres, B. A.,
Burne, J. F.,
Coles, H. S.,
Ishizuka, Y.,
and Jacobson, M., D.
(1993)
Science
262,
695-700[Abstract/Free Full Text]
|
| 2.
|
Thompson, C. B.
(1995)
Science
262,
1456-1462
|
| 3.
|
Vaux, D. L.,
and Strasser, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2239-2244[Abstract/Free Full Text]
|
| 4.
|
Bibel, M.,
and Barde, Y. A.
(2000)
Genes Dev.
14,
2919-2937[Free Full Text]
|
| 5.
|
Levi-Montalcini, R.
(1987)
EMBO J.
6,
1145-1154[Medline]
[Order article via Infotrieve]
|
| 6.
|
Rabizadeh, S.,
and Bredesen, D. E.
(1994)
Dev. Neurosci.
16,
207-211[Medline]
[Order article via Infotrieve]
|
| 7.
|
Klein, R.,
Jing, S. Q.,
Nanduri, V.,
O'Rourke, E.,
and Barbacid, M.
(1991)
Cell
65,
189-197[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Chao, M. V.,
Bothwell, M. A.,
Ross, A. H.,
Loprpwski, H.,
Lanahanm, A. A.,
Buck, C. R.,
and Sehgal, A.
(1986)
Science
232,
518-521[Abstract/Free Full Text]
|
| 9.
|
Johnson, D.,
Lanahan, A.,
Buck, C. R.,
Sehgal, A.,
Morgan, C.,
Mercer, E.,
Bothwell, M.,
and Chao, M. V.
(1986)
Cell
47,
545-554[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Peng, X.,
Greene, L. A.,
Kaplan, D. R.,
and Stephens, R. M.
(1995)
Neuron
15,
395-406[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Yao, R.,
and Cooper, G. M.
(1995)
Science
267,
2003-2006[Abstract/Free Full Text]
|
| 12.
|
Kaplan, D. R.,
and Stephens, R. M.
(1994)
J. Neurobiol.
25,
1404-1417[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Lachyankar, M. B.,
Condon, P. J.,
Quesenberry, P. J.,
Litofsky, N. S.,
Recht, L. D.,
and Ross, A. H.
(1997)
Exp. Neurol.
144,
350-360[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Dechant, G.,
and Barde, Y. A.
(1997)
Curr. Opin. Neurobiol.
7,
413-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Bredesen, D. E.,
and Rabizadeh, S.
(1997)
Trends Neurosci.
18,
321-326
|
| 16.
|
Maidan, M.,
and Lachance, C.
(1997)
J. Neurosci.
17,
6988-6998[Abstract/Free Full Text]
|
| 17.
|
Miller, F. D.,
and Kaplan, D. R.
(1998)
Cell Death Differ.
5,
343-345[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Frade, J. M.,
Rodriguez-Tebar, A.,
and Barde, Y. A.
(1996)
Nature
383,
166-168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
von Schack, D.,
Casademunt, E.,
Schweigreiter, R.,
Meyer, M.,
Bibel, M.,
and Dechant, G.
(2001)
Nature Neurosci.
4,
977-978[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Casaccia-Bonnefil, P.,
Carter, B. D.,
Dobrowsky, R. T.,
and Chao, M. V.
(1996)
Nature
383,
716-719[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Khursigera, G.,
Orlinick, J. R.,
and Chao, M. V.
(1999)
J. Biol. Chem.
274,
2597-2600[Abstract/Free Full Text]
|
| 22.
|
Ye, X.,
Mehlen, P.,
Rabizadeh, S.,
VanArsdale, T.,
Zhang, H.,
Shin, H.,
Wang, J. J. L.,
Leo, E.,
Zapata, J.,
Hauser, C. A.,
Reed, J. C.,
and Bredesen, D. E.
(1999)
J. Biol. Chem.
274,
30202-30208[Abstract/Free Full Text]
|
| 23.
|
Irie, S.,
Hachiya, T.,
Rabizadeh, S.,
Maruyama, W.,
Mukai, J., Li, Y.,
Reed, J. C.,
Bredesen, D. E.,
and Sato, T. A.
(1999)
FEBS Lett.
460,
191-198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Chittka, A.,
and Chao, M. V.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10705-10710[Abstract/Free Full Text]
|
| 25.
|
Casademunt, E.,
Carter, B. D.,
Benzel, I.,
Frade, J. M.,
Dechant, G.,
and Barde, Y. A.
(1999)
EMBO J.
18,
6050-6061[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Salehi, A. H.,
Roux, P. P.,
Kubu, C. J.,
Zeindler, C.,
Bhakar, A.,
Tannis, L. L.,
Verdi, J. M.,
and Barker, P. A.
(2000)
Neuron
27,
279-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Yamashita, T.,
Tucker, K. L.,
and Barde, Y. A.
(1999)
Neuron
24,
585-593[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Mukai, J.,
Hachiya, T.,
Shoji-Hoshino, S.,
Kimura, M. T.,
Nadano, D.,
Suvanto, P.,
Hanaoka, T., Li, Y.,
Irie, S.,
Greene, L. A.,
and Sato, T. A.
(2000)
J. Biol. Chem.
275,
17566-17570[Abstract/Free Full Text]
|
| 29.
|
Brown, A. L.,
and Kay, G. F.
(1999)
Hum. Mol. Genet.
8,
611-619[Abstract/Free Full Text]
|
| 30.
|
Park, J. A.,
Lee, J.-Y.,
Sato, T. A.,
and Koh, J.-Y.
(2000)
J. Neurosci.
20,
9096-9103[Abstract/Free Full Text]
|
| 31.
|
Kimura, M. T.,
Irie, S.,
Shoji-Hoshino, S.,
Mukai, J.,
Nadano, D.,
Oshimura, M.,
and Sato, T. A.
(2001)
J. Biol. Chem.
276,
17291-17300[Abstract/Free Full Text]
|
| 32.
|
Gorlich, D.,
and Mattaj, I. W.
(1996)
Science
271,
1513-1518[Abstract]
|
| 33.
|
Fischer, U.,
Huber, J.,
Boelens, W. C.,
Mattaj, I. W.,
and Lhrmann, R.
(1995)
Cell
82,
475-483[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Wen, W.,
Meinkoth, J. L.,
Tsien, R. Y.,
and Taylor, S. S.
(1995)
Cell
82,
463-473[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Fukuda, M.,
Gotoh, I.,
Gotoh, Y.,
and Nishida, E.
(1996)
J. Biol. Chem.
271,
20024-20028[Abstract/Free Full Text]
|
| 36.
|
Gu, C.,
Casaccia-Bonnefil, P.,
Srinivasan, A.,
and Chao, M. V.
(1999)
J. Neurosci.
19,
3043-3049[Abstract/Free Full Text]
|
| 37.
|
Stegh, A. H.,
Schickling, O.,
Ehret, A.,
Scaffidi, C.,
Petehansel, C.,
Hofmann, T. G.,
Grummt, I.,
Krammer, P. H.,
and Peter, M. E.
(1998)
EMBO J.
17,
5974-5986[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
McGahon, A. J.,
Martin, S. J.,
Bissonnette, R. P.,
Mahboubi, A.,
Shi, Y.,
Mogil, R. J.,
Nishioka, W. K.,
and Green, D. R.
(1995)
Methods Cell Biol.
46,
153-185[Medline]
[Order article via Infotrieve]
|
| 39.
|
Vojek, A. B.,
Hollenberg, S. M.,
and Cooper, J. A.
(1993)
Cell
74,
205-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kudo, N.,
Wolff, B.,
Sekimoto, T.,
Schreiner, E. P.,
Yoneda, Y.,
Yanagida, M.,
Horinouchi, S.,
and Yoshida, M.
(1998)
Exp. Cell Res.
242,
540-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Vandenabeele, P.,
Declercq, W.,
Beyaert, R.,
and Fiers, W.
(1995)
Trends Cell Biol.
5,
392-399[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Nagata, S.
(1997)
Cell
88,
355-365[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Tartaglia, L. A.,
Ayeres, T. M.,
Wong, G. H. W.,
and Goeddel, D. V.
(1993)
Cell
74,
845-853[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Liepinsh, E.,
Liag, L. L.,
Otting, G.,
and Ibanez, C. F.
(1997)
EMBO J.
16,
4999-5005[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Bogerd, H. P.,
Fridell, R. A.,
Benson, R. E.,
Hua, J.,
and Cullen, B. R.
(1996)
Mol. Cell. Biol.
16,
4207-4214[Abstract]
|
| 46.
|
Kim, F. J.,
Beeche, A. A.,
Hunter, J. J.,
Chin, D. J.,
and Hope, T. J.
(1996)
Mol. Cell. Biol.
16,
5147-5155[Abstract]
|
| 47.
|
Kumagai, A.,
and Dunphy, W. G.
(1999)
Genes Dev.
13,
1067-1072[Abstract/Free Full Text]
|
| 48.
|
Yang, J.,
Winkler, K.,
Yoshida, M.,
and Kornbluth, S.
(1999)
EMBO J.
18,
2174-2183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Seimiya, H.,
Sawada, H.,
Muramatsu, Y.,
Shimizu, M.,
Ohko, K.,
Yamane, K.,
and Tsuruo, T.
(2000)
EMBO J.
19,
2652-2661[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike